Autobio Diagnostics Co., Ltd. (SHA:603658)
China · Delayed Price · Currency is CNY 40.30
+0.43 (1.08%)
Jul 25, 2025, 3:00 PM CST
Autobio Diagnostics Market Cap
Autobio Diagnostics has a market cap or net worth of 23.03 billion as of July 25, 2025. Its market cap has decreased by -13.89% in one year.
Market Cap
23.03B
Enterprise Value
23.01B
Revenue
4.38B
Ranking
n/a
PE Ratio
20.35
Stock Price
40.30
Market Cap Chart
Since September 1, 2016, Autobio Diagnostics's market cap has increased from 8.82B to 23.03B, an increase of 161.09%. That is a compound annual growth rate of 11.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 23.03B | -7.77% |
| Dec 31, 2024 | 24.97B | -24.62% |
| Dec 29, 2023 | 33.12B | -8.65% |
| Dec 30, 2022 | 36.26B | 12.33% |
| Dec 31, 2021 | 32.28B | -50.70% |
| Dec 31, 2020 | 65.47B | 61.74% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Sep 1, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 375.59B |
| Shenzhen Mindray Bio-Medical Electronics | 280.39B |
| WuXi AppTec | 253.34B |
| Zhangzhou Pientzehuang Pharmaceutical., | 122.97B |
| Sichuan Biokin Pharmaceutical | 122.14B |
| Aier Eye Hospital Group | 121.87B |
| Shanghai United Imaging Healthcare | 112.42B |
| Yunnan Baiyao Group Co.,Ltd | 100.86B |